Person · CIK 1801050

Howard G. Welgus

Chief Medical Officer at Arcutis Biotherapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$6.8M

Noticed on Form 144$3.8M

Bought on Form 4$0

Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Arcutis Biotherapeutics ARQT	Common Stock	Directly	35,207	Oct 15, 2026 · Filing · EDGAR
Arcutis Biotherapeutics ARQT	Common Stock	By Trust	24,991	Aug 1, 2024 · Filing · EDGAR
Arcutis Biotherapeutics ARQT	Stock Option (right to buy) exercise $8.63, expires Jun 14, 2034, into Common Stock	Directly	15,778	Oct 15, 2026 · Filing · EDGAR
Arcutis Biotherapeutics ARQT	Stock Option (right to buy) exercise $7.51, expires May 31, 2033, into Common Stock	Directly	7,126	Oct 15, 2026 · Filing · EDGAR
Arcutis Biotherapeutics ARQT	Stock Option (right to buy) exercise $6.52, expires Nov 20, 2029, into Common Stock	Directly	5,752	Oct 15, 2026 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q4 2026	$127K	Not machine-readable
Q3 2026	$365K	Not machine-readable
Q2 2026	$519K	$239K
Q1 2026	$797K	$797K
Q4 2025	$744K	$744K
Q3 2025	$427K	$426K
Q2 2025	$433K	$433K
Q1 2025	$404K	$404K
Q4 2024	$304K	$304K
Q3 2024	$300K	$300K
Q2 2024	$80K	$80K
Q2 2023	$221K	$119K
Q1 2023	$261K	Not machine-readable
Q4 2022	$190K	Not machine-readable
Q3 2022	$295K	Not machine-readable
Q2 2022	$253K	Not machine-readable
Q1 2022	$53K	Not machine-readable
Q4 2021	$165K	Not machine-readable
Q3 2021	$161K	Not machine-readable
Q2 2021	$201K	Not machine-readable
Q1 2021	$212K	Not machine-readable
Q4 2020	$158K	Not machine-readable
Q3 2020	$125K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Arcutis Biotherapeutics ARQT · Merrill · 10b5-1 plan adopted Mar 11, 2025 · 11 notices
Apr 1, 2026	10,000 · ~$239K	Apr 1, 2026	Sold as noticed Sold 10,000 at $23.88 on Apr 1 · $239K Form 4	Filing · EDGAR
Mar 2, 2026	10,000 · ~$257K	Mar 2, 2026	Sold as noticed Sold 10,000 at $25.65 on Mar 2 · $257K Form 4	Filing · EDGAR
Feb 2, 2026	10,000 · ~$250K	Feb 2, 2026	Sold as noticed Sold 10,000 at $25.05 on Feb 2 · $250K Form 4	Filing · EDGAR
Jan 2, 2026	10,000 · ~$290K	Jan 2, 2026	Sold as noticed Sold 10,000 at $28.96 on Jan 2 · $290K Form 4	Filing · EDGAR
Dec 1, 2025	10,000 · ~$302K	Dec 1, 2025	Sold as noticed Sold 10,000 at $30.21 on Dec 1 · $302K Form 4	Filing · EDGAR
Nov 3, 2025	10,000 · ~$253K	Nov 3, 2025	Sold as noticed Sold 10,000 at $25.27 on Nov 3 · $253K Form 4	Filing · EDGAR
Oct 1, 2025	10,000 · ~$189K	Oct 1, 2025	Sold as noticed Sold 10,000 in 2 sales, Oct 1 to Oct 1 · $189K Form 4	Filing · EDGAR
Sep 2, 2025	10,000 · ~$156K	Sep 2, 2025	Sold as noticed Sold 10,000 at $15.64 on Sep 2 · $156K Form 4	Filing · EDGAR
Aug 1, 2025	10,000 · ~$143K	Aug 1, 2025	Sold as noticed Sold 10,000 in 2 sales, Aug 1 to Aug 1 · $143K Form 4	Filing · EDGAR
Jul 1, 2025	9,208 · ~$127K	Jul 1, 2025	Sold as noticed Sold 9,208 at $13.84 on Jul 1 · $127K Form 4	Filing · EDGAR
Jun 18, 2025	10,139 · ~$136K	Jun 18, 2025	Sold as noticed Sold 10,139 at $13.37 on Jun 18 · $136K Form 4	Filing · EDGAR
Arcutis Biotherapeutics ARQT · Merrill · 10b5-1 plan adopted Mar 5, 2024 · 11 notices
May 1, 2025	10,000 · ~$146K	May 1, 2025	Sold as noticed Sold 10,000 at $14.64 on May 1 · $146K Form 4	Filing · EDGAR
Apr 1, 2025	10,000 · ~$151K	Apr 1, 2025	Sold as noticed Sold 10,000 at $15.12 on Apr 1 · $151K Form 4	Filing · EDGAR
Mar 3, 2025	10,000 · ~$130K	Mar 3, 2025	Sold as noticed Sold 10,000 at $13.00 on Mar 3 · $130K Form 4	Filing · EDGAR
Feb 3, 2025	10,000 · ~$127K	Feb 3, 2025	Sold as noticed Sold 10,000 at $12.71 on Feb 3 · $127K Form 4	Filing · EDGAR
Jan 2, 2025	10,000 · ~$147K	Jan 2, 2025	Sold as noticed Sold 10,000 at $14.67 on Jan 2 · $147K Form 4	Filing · EDGAR
Dec 2, 2024	10,000 · ~$125K	Dec 2, 2024	Sold as noticed Sold 10,000 at $12.51 on Dec 2 · $125K Form 4	Filing · EDGAR
Nov 1, 2024	10,000 · ~$87K	Nov 1, 2024	Sold as noticed Sold 10,000 at $8.65 on Nov 1 · $87K Form 4	Filing · EDGAR
Oct 1, 2024	10,000 · ~$93K	Oct 1, 2024	Sold as noticed Sold 10,000 at $9.26 on Oct 1 · $93K Form 4	Filing · EDGAR
Sep 3, 2024	10,000 · ~$108K	Sep 3, 2024	Sold as noticed Sold 10,000 at $10.77 on Sep 3 · $108K Form 4	Filing · EDGAR
Aug 1, 2024	10,000 · ~$99K	Aug 1, 2024	Sold as noticed Sold 10,000 in 2 sales, Aug 1 to Aug 1 · $99K Form 4	Filing · EDGAR
Jun 4, 2024	10,000 · ~$80K	Jun 4, 2024	Sold as noticed Sold 10,000 in 2 sales, Jun 4 to Jun 4 · $80K Form 4	Filing · EDGAR
Arcutis Biotherapeutics ARQT · Merrill · No 10b5-1 plan stated · 1 notice
Jul 1, 2024	10,000 · ~$93K	Jul 1, 2024	Sold as noticed Sold 10,000 at $9.31 on Jul 1 · $93K Form 4	Filing · EDGAR
Arcutis Biotherapeutics ARQT · Merrill · 10b5-1 plan adopted Dec 16, 2022 · 1 notice
Apr 17, 2023	8,500 · ~$119K	Apr 17, 2023	Sold as noticed Sold 8,500 at $13.97 on Apr 17 · $119K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 48 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 4,728 at $26.93 on Oct 15, 2026 · $127K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 4,730 at $24.18 on Sep 15, 2026 · $114K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 4,730 at $26.18 on Aug 17, 2026 · $124K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 4,730 at $26.91 on Jul 15, 2026 · $127K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 635 at $25.67 on Jun 17, 2026 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 4,096 at $24.41 on Jun 15, 2026 · $100K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Arcutis Biotherapeutics (ARQT): Sold 7,144 at $22.99 on May 1, 2026 · $164K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 8,500 at $12.01 on Apr 6, 2023 · $102K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 8,500 at $16.98 on Feb 15, 2023 · $144K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 8,500 at $13.72 on Jan 17, 2023 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 3,403 at $20.01 on Nov 15, 2022 · $68K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 6,000 at $20.29 on Oct 4, 2022 · $122K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 6,000 at $24.80 on Aug 15, 2022 · $149K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 6,000 at $24.40 on Jul 18, 2022 · $146K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $20.62 on Jun 1, 2022 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $20.44 on May 2, 2022 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 7,500 at $20.02 on Apr 1, 2022 · $150K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $21.21 on Jan 3, 2022 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $20.16 on Dec 23, 2021 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $21.81 on Nov 1, 2021 · $55K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,500 at $23.87 on Oct 1, 2021 · $60K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 800 at $21.28 on Sep 1, 2021 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 4,200 at $20.71 on Sep 1, 2021 · $87K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 250 at $26.87 on Jul 1, 2021 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,950 at $26.03 on Jul 1, 2021 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 142 at $27.61 on Jun 1, 2021 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,058 at $27.06 on Jun 1, 2021 · $56K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 917 at $35.12 on May 3, 2021 · $32K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,283 at $34.56 on May 3, 2021 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,040 at $29.75 on Apr 1, 2021 · $31K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,160 at $29.25 on Apr 1, 2021 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 166 at $34.88 on Mar 1, 2021 · $6K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,034 at $34.33 on Mar 1, 2021 · $70K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 50 at $36.00 on Feb 1, 2021 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 350 at $35.02 on Feb 1, 2021 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,250 at $34.49 on Feb 1, 2021 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 550 at $33.45 on Feb 1, 2021 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,200 at $27.82 on Jan 4, 2021 · $61K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 263 at $27.36 on Dec 1, 2020 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,050 at $26.29 on Dec 1, 2020 · $28K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 887 at $25.20 on Dec 1, 2020 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,200 at $18.27 on Nov 2, 2020 · $40K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 390 at $25.18 on Oct 1, 2020 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,810 at $28.18 on Oct 1, 2020 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,172 at $24.38 on Sep 1, 2020 · $29K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 1,028 at $24.38 on Sep 1, 2020 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 67 at $25.63 on Aug 3, 2020 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Arcutis Biotherapeutics (ARQT): Sold 2,733 at $25.63 on Aug 3, 2020 · $70K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Arcutis Biotherapeutics ARQT Chief Medical Officer · filings 2020 to 2026 · sold $6.8M · $3.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 15, 2026	Option or RSU exercised or converted	+822	$6.52	$5K	36,663 direct	Filing · EDGAR
Oct 15, 2026	Option or RSU exercised or converted	+1,018	$7.51	$8K	37,681 direct	Filing · EDGAR
Oct 15, 2026	Option or RSU exercised or converted	+2,254	$8.63	$19K	39,935 direct	Filing · EDGAR
Oct 15, 2026	Sale under a 10b5-1 plan	−4,728	$26.93	$127K	35,207 direct	Filing · EDGAR
Oct 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−822			5,752 direct	Filing · EDGAR
Oct 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−1,018			7,126 direct	Filing · EDGAR
Oct 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−2,254			15,778 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted	+822	$6.52	$5K	37,297 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted	+1,019	$7.51	$8K	38,316 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted	+2,255	$8.63	$19K	40,571 direct	Filing · EDGAR
Sep 15, 2026	Sale under a 10b5-1 plan	−4,730	$24.18	$114K	35,841 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−822			6,574 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−1,019			8,144 direct	Filing · EDGAR
Sep 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−2,255			18,032 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted	+822	$6.52	$5K	37,931 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted	+1,019	$7.51	$8K	38,950 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted	+2,255	$8.63	$19K	41,205 direct	Filing · EDGAR
Aug 17, 2026	Sale under a 10b5-1 plan	−4,730	$26.18	$124K	36,475 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−822			7,396 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−1,019			9,163 direct	Filing · EDGAR
Aug 17, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−2,255			20,287 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted	+822	$6.52	$5K	38,565 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted	+1,019	$7.51	$8K	39,584 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted	+2,255	$8.63	$19K	41,839 direct	Filing · EDGAR
Jul 15, 2026	Sale under a 10b5-1 plan	−4,730	$26.91	$127K	37,109 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−822			8,218 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−1,019			10,182 direct	Filing · EDGAR
Jul 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−2,255			22,542 direct	Filing · EDGAR
Jun 17, 2026	Sale under a 10b5-1 plan	−635	$25.67	$16K	37,743 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted	+822	$6.52	$5K	39,200 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted	+1,019	$7.51	$8K	40,219 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted	+2,255	$8.63	$19K	42,474 direct	Filing · EDGAR
Jun 15, 2026	Sale under a 10b5-1 plan	−4,096	$24.41	$100K	38,378 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−822			9,040 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−1,019			11,201 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−2,255			24,797 direct	Filing · EDGAR
Jun 5, 2026	Grant or award from the company	+5,778			38,378 direct	Filing · EDGAR
Jun 5, 2026	Grant or award from the company Stock Option (right to buy)	+16,667			16,667 direct	Filing · EDGAR
May 1, 2026	Sale under a 10b5-1 plan	−7,144	$22.99	$164K	32,600 direct	Filing · EDGAR
Apr 1, 2026	Sale under a 10b5-1 plan	−10,000	$23.88	$239K	39,744 direct	Filing · EDGAR
Mar 2, 2026	Sale under a 10b5-1 plan	−10,000	$25.65	$257K	49,744 direct	Filing · EDGAR
Feb 2, 2026	Sale under a 10b5-1 plan	−10,000	$25.05	$250K	59,744 direct	Filing · EDGAR
Jan 2, 2026	Sale under a 10b5-1 plan	−10,000	$28.96	$290K	69,744 direct	Filing · EDGAR
Dec 1, 2025	Sale under a 10b5-1 plan	−10,000	$30.21	$302K	79,744 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−10,000	$25.27	$253K	89,744 direct	Filing · EDGAR
Oct 1, 2025	Option or RSU exercised or converted	+9,538	$1.68	$16K	109,744 direct	Filing · EDGAR
Oct 1, 2025	Sale under a 10b5-1 plan	−9,538	$18.92	$180K	100,206 direct	Filing · EDGAR
Oct 1, 2025	Sale under a 10b5-1 plan	−462	$18.92	$9K	99,744 direct	Filing · EDGAR
Oct 1, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−9,538			0 direct	Filing · EDGAR
Sep 2, 2025	Option or RSU exercised or converted	+10,000			110,206 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−10,000	$15.64	$156K	100,206 direct	Filing · EDGAR
Sep 2, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Aug 1, 2025	Option or RSU exercised or converted	+6,110			106,316 direct	Filing · EDGAR
Aug 1, 2025	Sale under a 10b5-1 plan	−6,110	$14.30	$87K	100,206 direct	Filing · EDGAR
Aug 1, 2025	Option or RSU exercised or converted	+3,890			104,096 direct	Filing · EDGAR
Aug 1, 2025	Sale under a 10b5-1 plan	−3,890	$14.30	$56K	100,206 direct	Filing · EDGAR
Aug 1, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−6,110			0 direct	Filing · EDGAR
Aug 1, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−3,890			0 direct	Filing · EDGAR
Jul 1, 2025	Sale under a 10b5-1 plan	−9,208	$13.84	$127K	100,206 direct	Filing · EDGAR
Jun 18, 2025	Sale under a 10b5-1 plan	−10,139	$13.37	$136K	109,414 direct	Filing · EDGAR

211 earlier transactions are in the filing list below.

All 118 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 19, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 15, 2026	Form 144	Could not read	EDGAR
Sep 17, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 15, 2026	Form 144	Could not read	EDGAR
Aug 19, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 17, 2026	Form 144	Could not read	EDGAR
Jul 17, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 15, 2026	Form 144	Could not read	EDGAR
Jun 17, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 17, 2026	Form 144	Could not read	EDGAR
Jun 15, 2026	Form 144	Could not read	EDGAR
Jun 9, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 5, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 1, 2026	Form 144	Could not read	EDGAR
Apr 3, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 1, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 4, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 2, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 2, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 6, 2026	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 2, 2026	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 3, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 3, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 4, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 2, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 2, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 20, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 18, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 16, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 5, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 3, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 1, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 4, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 3, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 6, 2025	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 2, 2025	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 3, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 2, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 5, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 1, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 3, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 1, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 5, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 3, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 1, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 2, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 1, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 18, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 6, 2024	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 4, 2024	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 2, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 18, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 17, 2023	Form 144	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 10, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 21, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 18, 2023	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 17, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 6, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 17, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 18, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 3, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 2, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 3, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 1, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 5, 2022	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 23, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 3, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 5, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 3, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 23, 2021	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jul 6, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 11, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jun 3, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 25, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
May 5, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 20, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Apr 5, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 18, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 3, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 17, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 8, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 3, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 14, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 6, 2021	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 16, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Dec 3, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 13, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Nov 4, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 16, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 5, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Oct 5, 2020	Form 4/A	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 16, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Sep 2, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 21, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 19, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 18, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Aug 5, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 16, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Mar 3, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Feb 4, 2020	Form 4	Arcutis Biotherapeutics ARQT	Filing · EDGAR
Jan 30, 2020	Form 3	Arcutis Biotherapeutics ARQT	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 1:00 AM ET. The filing on SEC.gov is the record.